Comment on: 'antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence'

MeSH terms

• Advisory Committees
• Antidepressive Agents / therapeutic use*
• Biomedical Research / trends
• Cost of Illness
• Depressive Disorder / drug therapy*
• Depressive Disorder / economics
• Evidence-Based Medicine
• Humans
• Research Design
• Selective Serotonin Reuptake Inhibitors / therapeutic use